Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-009921-28Phase 3Active
Phase 3, randomised, double-blind trial in breast cancer comparing Metformin with Placebo (2 arms). Primary endpoint: Breast cancer incidence. Started Jan 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-009921-28.